Cargando…

The Epidemiology of Functional Gastrointestinal Disorders in Mexico: A Population-Based Study

Aims. The frequency of functional gastrointestinal disorders (FGIDs) in the general population of Mexico is unknown. Methods. To determine the prevalence of FGIDs, associated depression, and health care utilization, a population-based sampling strategy was used to select 500 households in the State...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Colombo, Aurelio, Morgan, Douglas, Bravo-González, Dalia, Montiel-Jarquín, Alvaro, Méndez-Martínez, Socorro, Schmulson, Max
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313569/
https://www.ncbi.nlm.nih.gov/pubmed/22474443
http://dx.doi.org/10.1155/2012/606174
_version_ 1782228016303177728
author López-Colombo, Aurelio
Morgan, Douglas
Bravo-González, Dalia
Montiel-Jarquín, Alvaro
Méndez-Martínez, Socorro
Schmulson, Max
author_facet López-Colombo, Aurelio
Morgan, Douglas
Bravo-González, Dalia
Montiel-Jarquín, Alvaro
Méndez-Martínez, Socorro
Schmulson, Max
author_sort López-Colombo, Aurelio
collection PubMed
description Aims. The frequency of functional gastrointestinal disorders (FGIDs) in the general population of Mexico is unknown. Methods. To determine the prevalence of FGIDs, associated depression, and health care utilization, a population-based sampling strategy was used to select 500 households in the State of Tlaxcala, in central Mexico. Household interviews were conducted by two trained physicians using the Rome II Modular Questionnaire, a health-care and medication used questionnaire and the CES-D depression scale. Results. The most common FGIDs were IBS: 16.0% (95% CI: 12.9–19.5); functional bloating: 10.8% (8.2–13.9); unspecified functional bowel disorder: 10.6% (8.0–13.6); and functional constipation (FC): 7.4% (5.3–10.1). Uninvestigated heartburn was common: 19.6% (16.2–23.4). All FGIDs were equally prevalent among both genders, except for IBS (P = 0.001), IBS-C (P < 0.001), IBS-A/M (P = 0.049), and FC (P = 0.039) which were more frequent in women. Subjects with FGIDs reported higher frequencies of medical visits: 34.6 versus 16.8%; use of medications: 40.7 versus 21.6%; (both P < 0.001); and reported depression: 26.7 versus 6.7%, (P < 0.001). Conclusion. In this first population-based study of FGIDs in Mexico, heartburn, IBS, functional distension, and FC were common. Only IBS, IBS-C, IBS-A/M, and FC were more frequent in women. Finally, FGIDs in Mexico had an increased burden of health care utilization and depression.
format Online
Article
Text
id pubmed-3313569
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-33135692012-04-03 The Epidemiology of Functional Gastrointestinal Disorders in Mexico: A Population-Based Study López-Colombo, Aurelio Morgan, Douglas Bravo-González, Dalia Montiel-Jarquín, Alvaro Méndez-Martínez, Socorro Schmulson, Max Gastroenterol Res Pract Research Article Aims. The frequency of functional gastrointestinal disorders (FGIDs) in the general population of Mexico is unknown. Methods. To determine the prevalence of FGIDs, associated depression, and health care utilization, a population-based sampling strategy was used to select 500 households in the State of Tlaxcala, in central Mexico. Household interviews were conducted by two trained physicians using the Rome II Modular Questionnaire, a health-care and medication used questionnaire and the CES-D depression scale. Results. The most common FGIDs were IBS: 16.0% (95% CI: 12.9–19.5); functional bloating: 10.8% (8.2–13.9); unspecified functional bowel disorder: 10.6% (8.0–13.6); and functional constipation (FC): 7.4% (5.3–10.1). Uninvestigated heartburn was common: 19.6% (16.2–23.4). All FGIDs were equally prevalent among both genders, except for IBS (P = 0.001), IBS-C (P < 0.001), IBS-A/M (P = 0.049), and FC (P = 0.039) which were more frequent in women. Subjects with FGIDs reported higher frequencies of medical visits: 34.6 versus 16.8%; use of medications: 40.7 versus 21.6%; (both P < 0.001); and reported depression: 26.7 versus 6.7%, (P < 0.001). Conclusion. In this first population-based study of FGIDs in Mexico, heartburn, IBS, functional distension, and FC were common. Only IBS, IBS-C, IBS-A/M, and FC were more frequent in women. Finally, FGIDs in Mexico had an increased burden of health care utilization and depression. Hindawi Publishing Corporation 2012 2012-03-19 /pmc/articles/PMC3313569/ /pubmed/22474443 http://dx.doi.org/10.1155/2012/606174 Text en Copyright © 2012 Aurelio López-Colombo et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
López-Colombo, Aurelio
Morgan, Douglas
Bravo-González, Dalia
Montiel-Jarquín, Alvaro
Méndez-Martínez, Socorro
Schmulson, Max
The Epidemiology of Functional Gastrointestinal Disorders in Mexico: A Population-Based Study
title The Epidemiology of Functional Gastrointestinal Disorders in Mexico: A Population-Based Study
title_full The Epidemiology of Functional Gastrointestinal Disorders in Mexico: A Population-Based Study
title_fullStr The Epidemiology of Functional Gastrointestinal Disorders in Mexico: A Population-Based Study
title_full_unstemmed The Epidemiology of Functional Gastrointestinal Disorders in Mexico: A Population-Based Study
title_short The Epidemiology of Functional Gastrointestinal Disorders in Mexico: A Population-Based Study
title_sort epidemiology of functional gastrointestinal disorders in mexico: a population-based study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313569/
https://www.ncbi.nlm.nih.gov/pubmed/22474443
http://dx.doi.org/10.1155/2012/606174
work_keys_str_mv AT lopezcolomboaurelio theepidemiologyoffunctionalgastrointestinaldisordersinmexicoapopulationbasedstudy
AT morgandouglas theepidemiologyoffunctionalgastrointestinaldisordersinmexicoapopulationbasedstudy
AT bravogonzalezdalia theepidemiologyoffunctionalgastrointestinaldisordersinmexicoapopulationbasedstudy
AT montieljarquinalvaro theepidemiologyoffunctionalgastrointestinaldisordersinmexicoapopulationbasedstudy
AT mendezmartinezsocorro theepidemiologyoffunctionalgastrointestinaldisordersinmexicoapopulationbasedstudy
AT schmulsonmax theepidemiologyoffunctionalgastrointestinaldisordersinmexicoapopulationbasedstudy
AT lopezcolomboaurelio epidemiologyoffunctionalgastrointestinaldisordersinmexicoapopulationbasedstudy
AT morgandouglas epidemiologyoffunctionalgastrointestinaldisordersinmexicoapopulationbasedstudy
AT bravogonzalezdalia epidemiologyoffunctionalgastrointestinaldisordersinmexicoapopulationbasedstudy
AT montieljarquinalvaro epidemiologyoffunctionalgastrointestinaldisordersinmexicoapopulationbasedstudy
AT mendezmartinezsocorro epidemiologyoffunctionalgastrointestinaldisordersinmexicoapopulationbasedstudy
AT schmulsonmax epidemiologyoffunctionalgastrointestinaldisordersinmexicoapopulationbasedstudy